Outstanding 12-month First-in-human Data from Xeltis’ aXess Hemodialysis Vascular Conduit Trial Presented at VEITHsymposium 2023
Xeltis, a leading developer of transformative implants that enable the [...]
Xeltis, a leading developer of transformative implants that enable the [...]
The two presentations were made at the VEITHsymposium, a major [...]
This collaboration will enable clinical trial sponsors to quantify the [...]
“During the autumn, we have visited several of our active [...]
Non-melanoma Skin Cancer: Treatment options include surgery, radiation, and cryotherapy. [...]
PK051 is a combined drug that targets disaggregates of amyloid-β [...]
To assess differences in the microstructural improvement of brain fiber [...]
Valentina Milanova, Founder of Daye, said: “Time is of the [...]
Utilizing Lunit INSIGHT MMG, an FDA-cleared and CE-marked AI solution [...]
“So far in the study, the SynerFuse procedure has been [...]